Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet-activating factor and related lipid mediators.

S M Prescott1, G A Zimmerman, D M Stafforini

  • 1The Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112, USA. steve.prescott@hci.utah.edu

Annual Review of Biochemistry
|August 31, 2000
PubMed
Summary

Platelet-activating factor (PAF), a key inflammation mediator, has its synthesis and degradation tightly regulated. Recent advances in understanding PAF receptor interactions and protein regulation are paving the way for further research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retinoic acid receptor-α regulates synthetic events in human platelets.

Journal of thrombosis and haemostasis : JTH·2017
Same author

Combined variants in factor VIII and prostaglandin synthase-1 amplify hemorrhage severity across three generations of descendants.

Journal of thrombosis and haemostasis : JTH·2016
Same author

Non-genomic activities of retinoic acid receptor alpha control actin cytoskeletal events in human platelets.

Journal of thrombosis and haemostasis : JTH·2016
Same author

Diacylglycerol kinase η modulates oncogenic properties of lung cancer cells.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2013
Same author

Dengue induces platelet activation, mitochondrial dysfunction and cell death through mechanisms that involve DC-SIGN and caspases.

Journal of thrombosis and haemostasis : JTH·2013
Same author

The septic milieu triggers expression of spliced tissue factor mRNA in human platelets.

Journal of thrombosis and haemostasis : JTH·2011

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Immunology

Background:

  • Platelet-activating factor (PAF) is a potent phospholipid mediator involved in diverse physiological processes, notably inflammation.
  • PAF's biological actions are tightly controlled through regulated synthesis, transport, and degradation pathways.
  • Structurally similar phospholipids from nonenzymatic oxidation can activate the PAF receptor, bypassing typical regulatory mechanisms.

Purpose of the Study:

  • To elucidate the biochemical basis of Platelet-Activating Factor (PAF) regulation.
  • To understand how nonenzymatically oxidized phospholipids interact with the PAF receptor.
  • To explore the role of PAF acetylhydrolase in regulating PAF-like compounds.

Main Methods:

  • Isolation of cDNA clones encoding key proteins involved in PAF regulation.

Related Experiment Videos

  • Biochemical analysis of PAF synthesis, transport, and degradation.
  • Investigation of PAF receptor binding by oxidized phospholipids.

    • Main Results:

    • Significant progress has been made in identifying and characterizing proteins that regulate PAF metabolism.
    • The role of PAF acetylhydrolase in controlling oxidized phospholipid activity has been highlighted.
    • Understanding of the biochemical control mechanisms governing PAF actions has advanced.

    Conclusions:

    • Recent molecular and biochemical insights provide a foundation for further studies on PAF.
    • Future research will focus on the structural basis of PAF receptor specificity.
    • The precise physiological roles of PAF in various biological events are being further elucidated.